You're reading the free version. Trader adds the live tape and alerts.
Start tracking
PALI Exercise Disclosure
Finley John David · SEC Form 4 · Filed Jul 8, 2026
Exercise
Reported value range
Not reported
Finley John David CEO, CFO
PALI
Palisade Bio, Inc.
PALI
Transaction date
Jul 6, 2026
Public filing date
Jul 8, 2026
Filing lag
Filed 2 days later
PALI daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 335,167 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001493152-26-032559
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$303.44K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Palisade Bio, Inc. PALI | Sale | Jul 7, 2026 | $303.34K |
| Palisade Bio, Inc. PALI | Exercise | Jul 7, 2026 | $93.1 |
| Palisade Bio, Inc. PALI | Exercise | Jul 7, 2026 | $0 |
| Palisade Bio, Inc. PALI Current | Exercise | Jul 6, 2026 | Not reported |
| Palisade Bio, Inc. PALI | Exercise | Jul 6, 2026 | $0 |